Cor Vasa 2021, 63(1):86-89 | DOI: 10.33678/cor.2020.104

(What are the benefits of vaccination for the patients with cardiovascular diseases?)

Petra Macounová, Rastislav Maďar
Ústav epidemiologie a ochrany veřejného zdraví, Lékařská fakulta Ostravské univerzity, Ostrava

Vaccination against some infectious diseases provides protection not only against themselves, but has also been shown to have cardioprotective effects, both in patients with pre-existing cardiovascular disease and in healthy individuals. The article discusses the importance of vaccination against influenza, pneumococcal disease, herpes zoster and their effect on cardiovascular disease, or their effect in the prevention of cardiovascular events.

Keywords: Cardiovascular disease, Cardiovascular events, Infection, Prevention, Vaccination, Vaccine

Received: October 19, 2020; Revised: October 19, 2020; Accepted: November 15, 2020; Published: February 25, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Macounová P, Maďar R. (What are the benefits of vaccination for the patients with cardiovascular diseases?). Cor Vasa. 2021;63(1):86-89. doi: 10.33678/cor.2020.104.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adults with Heart Disease: Vaccinations are an Important Part of Protecting Your Health. CDC: Centers for Disease Control and Prevention [online]. 2016. Navštíveno 16. 1. 2020. Dostupné z: https://www.cdc.gov/vaccines/hcp/adults/downloads/matte-heart-disease-consumer.pdf
    2. Heart Disease, Stroke, or Other Cardiovascular Disease and Adult Vaccination. CDC: Centers for Disease Control and Prevention [online]. 2016. Navštíveno 16. 1. 2020. Dostupné z: https://www.cdc.gov/vaccines/adults/rec-vac/health-conditions/heart-disease.html
    3. Smetana J, Kosina P, Bostikova V, et al. Očkování u rizikových skupin pacientů v ordinaci praktického lékaře pro dospělé. Medicine for practice 2013;10:178-182.
    4. Kynčl J, Havlíčková M. Význam očkování proti chřipce a jeho optimální načasování. Státní zdravotní ústav [online]. Navštíveno 15. 1. 2020. Dostupné z: http://www.szu.cz/tema/prevence/vyznam-ockovani-proti-chripce-a-jeho-optimalni-nacasovani
    5. Chlíbek R. Očkování rizikových skupin pacientů. Medical Tribune CZ [online] 2018. Navštíveno 15. 1. 2020. Dostupné z: https://www.tribune.cz/clanek/44178
    6. Vaccination and Patients with Chronic Conditions: Background report. In: Commissioned by the European Patients' Forum [online] 2018 [cit. 2020-01-16].
    7. Česko. Zákon č. 48/1997 Sb.: Zákon o veřejném zdravotním pojištění a o změně a doplnění některých souvisejících zákonů. In: Zákony pro lidi. Dostupné také z: https://www.zakonyprolidi.cz/cs/1997-48/zneni-20200101
    8. Sršeň V. Úhrada očkování proti chřipce. Všeobecná zdravotní pojišťovna České republiky [online]. Navštíveno 19. 1. 2020. Dostupné z: https://www.vzp.cz/o-nas/tiskove-centrum/otazky-tydne/uhrada-ockovani-proti-chripce
    9. Tichý O. Vakcíny na očkování proti pneumokokům. Všeobecná zdravotní pojišťovna České republiky [online]. Navštíveno 19. 1. 2020. Dostupné z: https://www.vzp.cz/o-nas/tiskove-centrum/otazky-tydne/vakciny-na-ockovani-proti-pneumokokum
    10. Kwong JC, Schwartz KL, Campitelli MA, et al. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med 2018;378:345-353. Go to original source... Go to PubMed...
    11. Kynčl J. Význam očkování proti chřipce u osob s kardiovaskulárním onemocněním. Epidemiol Mikrobiol Imunol 2014;63:246-248.
    12. Veljkovic V, Glisic S, Veljkovic N, et al. Influenza vaccine as prevention for cardiovascular diseases: Possible molecular mechanism. Vaccine 2014;32:6569-6575. Go to original source... Go to PubMed...
    13. Loomba RS, Aggarwal S, Shah PH, Arora RR. Influenza Vaccination and Cardiovascular Morbidity and Mortality. J Cardiovasc Pharmacol Ther 2012;17:277-283. Go to original source... Go to PubMed...
    14. Davis MM, Taubert K, Benin AL, et al. Influenza Vaccination as Secondary Prevention for Cardiovascular Disease. J Am Coll Cardiol 2006;48:1498-1502. Go to original source... Go to PubMed...
    15. Aidoud A, Marlet J, Angoulvant D, et al. Influenza vaccination as a novel means of preventing coronary heart disease: Effectiveness in older adults. Vaccine 2020;38:4944-4955. Go to original source... Go to PubMed...
    16. Lelekis D, Stefani M. Prevention of Pneumococcal Disease in Patients with Chronic Cardiometabolic Diseases. International Journal of Caring Sciences 2016;9: 1124-1128.
    17. Çelik A. Vaccination of Adults with Heart Failure and Chronic Heart Conditions: Consensus Report. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology [online]. 2018. Navštíveno 21. 1. 2021. DOI: 10.5543/tkda.2018.37048. Dostupné z: http://archivestsc.com/jvi.aspx?un=TKDA-37048 Go to original source...
    18. Ciszewski A. Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases. Vaccine 2018;36:202-206. Go to original source... Go to PubMed...
    19. Vlachopoulos CV, Terentes-Printzios DG, Aznaouridis KA, et al. Association between pneumococcal vaccination and cardiovascular outcomes: a systematic review and meta- -analysis of cohort studies. Eur J Prev Cardiol 2015;22:1185-1199. Go to original source... Go to PubMed...
    20. Ren S, Hure A, Peel R, et al. Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: The Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE). Am Heart J 2016;177:58-65. Go to original source... Go to PubMed...
    21. Zuin M, Rigatelli G, Adami A. Cerebrovascular events after herpes zoster infection: a risk that should be not underestimated. J Neurovirol 2019;25:439-447. Go to original source... Go to PubMed...
    22. Klaric JS, Beltran TA, McClenathan BM. An Association Between Herpes Zoster Vaccination and Stroke Reduction Among Elderly Individuals. Mil Med 2019;184(Suppl 1):126-132. Go to original source... Go to PubMed...
    23. Erskine N, Tran H, Levin L, et al. A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PLoS One 2017;12:e0181565. Go to original source... Go to PubMed...
    24. Wu PH, Lin YT, Lin CY, et al. A nationwide population-based cohort study to identify the correlation between heart failure and the subsequent risk of herpes zoster. BMC Infectious Diseases 2015;15:17. Go to original source... Go to PubMed...
    25. Shingrix: Souhrn údajů o přípravku. Státní ústav pro kontrolu léčiv [online]. [cit. 2020-05-20]. Dostupné z: http://www.sukl.cz/modules/medication/detail.php?code=0222844&tab=texts

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes